InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by GARCIA PETER S, Chief Financial Officer. Director active across 1 companies, notably ALX Oncology Holdings INC. In total, 10 filings have been recorded. The latest transaction was disclosed on 7 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
€23,6396,637 shares@ €3.56170.0087% mcap8.0% of flow
Common Stock
SEC:0001209191-22-007887·
€23,6396,637 shares@ €3.56170.0087% mcap4.0% of flow
Common Stock
SEC:0001209191-22-007887:0·
€25,3967,229 shares@ €3.5130.0093% mcap8.5% of flow
Common Stock
SEC:0001209191-21-060910·
€25,3967,229 shares@ €3.5130.0093% mcap4.3% of flow
Common Stock
SEC:0001209191-21-060910:0·
€4,9441,426 shares@ €3.46720.0018% mcap1.7% of flow
Common Stock
SEC:0001209191-21-056787·
€4,9441,426 shares@ €3.46720.0018% mcap0.8% of flow
Common Stock
SEC:0001209191-21-056787:0·
€208,43760,000 shares@ €3.4740.076% mcap70.1% of flow
Common Stock
SEC:0001209191-21-053218·
€208,43760,000 shares@ €3.4740.076% mcap35.1% of flow
Common Stock
SEC:0001209191-21-053218:0·
€34,84310,000 shares@ €3.48430.013% mcap11.7% of flow
Common Stock
SEC:0001209191-21-052397·
€34,84310,000 shares@ €3.48430.013% mcap5.9% of flow
Common Stock
SEC:0001209191-21-052397:0·
10 of 10 declarations
About GARCIA PETER S
Peter S. Garcia is the Chief Financial Officer at ALX Oncology Holdings Inc. He oversees financial management and the company's financial strategy. His role is essential in ensuring financial sustainability and growth.
